Silver Grove Financial Group »

Avalo Therapeutics Ord shares owned by Silver Grove Financial Group

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Silver Grove Financial Group from 13F filings

Historical chart of Silver Grove Financial Group investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Silver Grove Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Silver Grove Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $15 1 15.00

More positions owned by Silver Grove Financial Group

Main Sector MF Closed and MF Open (SECT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Ishares Tr Core Us Aggbd Et (AGG)
Nvidia Corp Common Stock (NVDA)
Apple (AAPL)
Invesco Qqq MF Closed and MF Open (QQQ)
Microsoft Corporation (MSFT)
Amazon Common Stock (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Jpmorgan Chase Common Stock (JPM)
Broadcom (AVGO)
Ishares Tr National Mun Etf (MUB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Silver Grove Financial Group

Top funds holding Avalo Therapeutics Ord

BVF
Logos Global Management
Nantahala Capital Management
UBS Group
Affinity Asset Advisors
Point72 Asset Management
Caligan Partners
Millennium Management
Vanguard Group
TCG Crossover Management
Balyasny Asset Management
Vanguard Capital Management
RA Capital Management
Bank of America Corporation
Ikarian Capital

View all funds holding Avalo Therapeutics Ord